toxylact: a07c electrolytes with carbohydrates

The first professional lActological database in the word

ATC group A07C “Electrolytes with carbohydrates” comprises oral rehydration salt (ORS) formulations containing balanced mixtures of sodium, other electrolytes, and glucose or other carbohydrates, used to prevent and treat dehydration from diarrhea and considered compatible with breastfeeding.atcddd.fhi+3

ATC A07C overview

A07C is defined as “Electrolytes with carbohydrates” within the broader A07 group of antidiarrheals, intestinal anti‑inflammatory and anti‑infective agents. Its main subgroup A07CA encompasses oral rehydration salt formulations designed for enteral correction of water and electrolyte losses, distinct from parenteral electrolyte solutions (B05).atcddd.fhi+2

Pharmacology and mechanism

ORS formulations in A07C contain carefully matched concentrations of sodium, chloride, potassium, citrate or bicarbonate, and glucose (or similar carbohydrates), based on the WHO reduced osmolarity standard. Glucose facilitates sodium and water absorption via the sodium–glucose co‑transport mechanism in the small intestine, allowing effective rehydration even when diarrheal losses continue.who+1

Therapeutic indications

A07C oral rehydration solutions are indicated for prevention and treatment of dehydration due to acute diarrhea in all age groups, including infants, children, pregnant women, and adults. They are also used in other conditions with significant fluid and electrolyte loss (for example vomiting, heat‑related dehydration), but their principal role is in community and clinical management of diarrheal disease.medicalguidelines.msf+2

Dosing and administration context

ORS dosing is guided by the degree of dehydration: for example, children may receive 50–100 ml/kg over 3–4 hours for mild to moderate dehydration, while adults typically take 200–400 ml after each loose stool, with maintenance dosing thereafter. Solutions are prepared exactly as directed (one sachet per specified volume of safe water) to preserve the correct osmolarity and electrolyte balance.medicalguidelines.msf+2

Pharmacokinetics relevant to lactation

The electrolytes and glucose in ORS are normal dietary and physiological constituents; they are absorbed via the intestinal mucosa into the maternal circulation and then managed by usual homeostatic mechanisms. At recommended doses, ORS does not significantly alter maternal electrolyte balance beyond correcting dehydration, and any modest changes are within normal dietary variation, making clinically relevant changes in breast milk composition unlikely.pubmed.ncbi.nlm.nih+2

Maternal safety and adverse effects

When used as directed, ORS is generally safe; over‑concentrated solutions, excessive intake, or use in certain renal or cardiac conditions may theoretically contribute to sodium overload, but standard dosing regimens are explicitly designed to minimize such risks. Common mild adverse effects include transient bloating or nausea; serious events typically reflect underlying severe dehydration or comorbid disease rather than ORS itself.who+2

Lactation safety assessment

Evidence and guidelines emphasize that breastfeeding should be continued alongside ORS in infants with diarrhea, and that ORS is safe in breastfeeding mothers, with no contraindication to its use. Lactation‑focused resources for antidiarrheal therapy state that rehydration solutions with balanced sugar and salts are the optimal treatment for mothers with diarrheal fluid loss, and that they can be taken while breastfeeding normally.pubmed.ncbi.nlm.nih+4

Effects on the breastfed infant

In breastfed infants with diarrhea, ORS is administered directly to the child in addition to breast milk, and clinical data show that such use does not cause hypernatremia when standard formulations and protocols are followed. When the mother takes ORS for her own dehydration, the additional electrolytes and glucose may subtly reflect in milk as part of normal metabolic flux but are not expected to adversely affect the infant; continued breastfeeding reduces dehydration risk and improves outcomes in infant diarrheal illness.pubmed.ncbi.nlm.nih+3

Practical recommendations in breastfeeding

For breastfeeding women with diarrhea, best practice is to continue breastfeeding freely, drink according to thirst, and use ORS sachets to replace excess fluid and electrolyte loss. In infants, oral rehydration therapy should be combined with ongoing breastfeeding, with caregivers instructed not to dilute ORS incorrectly and to seek medical attention if danger signs (persistent vomiting, lethargy, blood in stool, or worsening dehydration) appear.pubmed.ncbi.nlm.nih+5

Role in toxico‑lactological context

Within a toxico‑lactological framework, A07C oral rehydration salts are supportive, non‑pharmacologically active “nutrient–electrolyte” therapies rather than xenobiotics, and they play a central role in mitigating the systemic consequences of diarrhea in both mothers and breastfed infants. Their established safety, physiological composition, and strong evidence base for reducing dehydration and mortality confer a clearly favorable risk–benefit profile in breastfeeding and make them a cornerstone of diarrheal management alongside safe antidiarrheal medications.pubmed.ncbi.nlm.nih+3

Recent ARTICLES

July 24

Abdominal Compartment Syndrome

PWhile the formal term and its consensus definitions were codified by the World Society of the Abdominal Compartment Syndrome (WSACS) only in the early 2000s, the physiological underpinnings have been observed for over 150 years. In 1863, the French physiologist Etienne-Jules Marey was the first to document the reciprocal relationship between intra-abdominal pressure (IAP) and respiratory function, noting that the expansion of the abdominal cavity directly impacted the efficiency of the thoracic bellows.

July 18

Assessment of Postoperative Fever

For the physician and the student of medicine, the assessment of postoperative fever is not merely a task of temperature monitoring, but a diagnostic journey that requires a nuanced understanding of immunology, physiology, and clinical timing. Guided by the principle of "Primum non nocere," this report seeks to bridge the gap between complex pathophysiological mechanisms and the empathetic care of the patient, providing a comprehensive framework for identifying, understanding, and managing this common clinical challenge.

July 14

Clinical Review of Congenital and Acquired Cystic Kidney Diseases

The healing arts, as envisioned by the ancient traditions of medicine, seek not merely the eradication of pathology but the restoration of a delicate equilibrium between the body’s internal environment and the external world. In the realm of nephrology, cystic diseases of the kidney represent a profound disruption of this balance.

Spotlight

A Comprehensive Analysis of Complement System Deficiencies in Pediatric and Adult Populations

The human immune system is a tapestry of ancient evolutionary mechanisms and highly specialized adaptive responses, woven together to maintain the delicate equilibrium of health. At the heart of this architecture lies the complement system, a complex network of over fifty proteins that function as the primordial vanguard of innate immunity. Named for its ability to "complement" the action of antibodies, this system serves as a bridge between the immediate, non-specific recognition of pathogens and the targeted, long-term memory of the adaptive immune response. However, when this sentinel falls silent due to genetic or acquired deficiencies, the result is a state of nuanced immunosuppression that significantly alters the human clinical landscape across all ages.